Clinical Trials Browser

Differentiated Thyroid Cancer × pembrolizumab × Endocrine × Clear all

NCT05852223 2025-04-13

NePenThe

Phase 2 Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer